B-cell Precursor Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for B-cell Precursor Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating subcutaneous blinatumomab in children with relapsed/refractory and MRD-positive B-cell precursor acute…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL [Phase 1, Phase 2]
The document provides a clinical trial update for a study evaluating subcutaneous blinatumomab in participants with relapsed/refractory and …
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Study of Blinatumomab Administration in Chinese Pediatric Participants With Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia (R/R B-ALL) [Phase 2]
A Phase 2 clinical trial update describing blinatumomab administration in Chinese pediatric participants with relapsed/refractory B-cell pre…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Venetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) [Phase 1, Phase 2]
This document describes a Phase 1/2 trial evaluating the combination of venetoclax with blinatumomab in adults with relapsed or refractory B…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 [Phase 1]
Phase 1 study of autologous CD19-targeted CAR-T cells for precursor B-cell acute lymphoblastic leukemia. The trial status is active but not …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: NGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALL [NA]
This document describes a planned clinical trial to evaluate minimal residual disease-guided treatment with blinatumomab for pediatric B cel…
-
CLINICAL_TRIALS research · 2012-10-24Clinical Trial Update: Pharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma. [Phase 1, Phase 2]
Terminated Phase 1/2 pharmacokinetic study of forodesine in children with relapsed or refractory T-cell or B-cell precursor acute lymphoblas…